SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-026043
Filing Date
2022-07-20
Accepted
2022-07-20 16:11:40
Documents
13
Period of Report
2022-07-19
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-8k_20220719.htm   iXBRL 8-K 51879
2 EX-99.1 asmb-ex991_15.htm EX-99.1 22939
  Complete submission text file 0001564590-22-026043.txt   211335

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asmb-20220719.xsd EX-101.SCH 5601
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20220719_lab.xml EX-101.LAB 18588
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20220719_pre.xml EX-101.PRE 11044
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20220719_htm.xml XML 3438
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 221094352
SIC: 2834 Pharmaceutical Preparations